ESSA Pharma Inc.: cash_and_restricted_cash
| Value | {"amount": 91683074, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2024-03-31) |
| Status | current |
| Entity | ESSA Pharma Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:47:48.155835+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bcc00ad5-b5b2-45c9-a4df-7c8d11ac8363
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-008053 · Open the official SEC filing →Retrieved: 2026-08-19T16:47:48.155835+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001633932/cash-and-restricted-cash/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bcc00ad5-b5b2-45c9-a4df-7c8d11ac8363
History
- no predecessors — first report